In October 2022 FDA has approved Remdesivir for the treatment of COVID-19, besides, some medications such as Molnupiravir are in advanced stages of approval
Lets break it down
Patients using Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DoD), TRICARE or any other federal or state government program (collectively, Government Programs) to pay for their Genentech medicine are not eligible
It also helps research teams focus on what can be documented: COA details, analytical methods, identity evidence, purity evidence, lot number consistency, and RUO labeling
Hughey S, Kotler J, Cole J, Jewett F, Checchi K, Lin A
-Improves metabolism